The Newsroom

Investigations  /  07.24.2020

Investigation of Insperity, Inc.

You Have Legal Options

Insperity, Inc. (NSP) Accused of Misleading Shareholders  

In February 2019, Insperity reported its fourth quarter and full year 2018 financials that touted significant year-over-year growth. Then, in April 2019, Insperity lauded “record” first quarter 2019 results and raised its ambitious full-year 2019 guidance. As a result of its auspicious financial reports and the implied success of its business model, Insperirty’s stock price increased dramatically during the first half of 2019. Despite its previous positive financials, in July 2019, Insperity offered disappointing third quarter 2019 guidance and reduced its full-year 2019 guidance, citing an anomalous increase in large medical claim costs. Then, in November 2019, Insperity released third quarter 2019 results that significantly missed analysts’ estimates and were materially down year-over-year, once again citing the large medical claim costs that Insperity continued to assure were an anomaly. Finally, on February 11, 2020, Insperity revealed for the third time that large medical claims had negatively impacted the Company and offered a lackluster guidance for first quarter and full-year 2020. Consequently, analysts lowered their views on Insperity stock stating “after three quarters, rising jumbo claims appear to be a trend, not aberrational.” On this news, Insperity’s share price fell $17.44 per share, or 20%, to close at $70.71 per share.

  • If you would like more information about your rights and potential remedies please send us a message. 

  • Please Note: Neither the submission to nor the receipt of information by Robbins LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns